Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced pulmonary disease.

D H Bryant1

  • 1Cardiothoracic Unit, St Vincent's Hospital, Darlinghurst, NSW.

The Medical Journal of Australia
|June 1, 1992
PubMed
Summary

Drug-induced pulmonary disease is a notable concern, with airway dysfunction being common. Early recognition and drug withdrawal are key to reversible outcomes in patients experiencing respiratory side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?

The European respiratory journal·2005
Same author

Allergy to laboratory animals among animal handlers.

The Medical journal of Australia·1995
Same author

Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction.

Annals of internal medicine·1993
Same author

Changes in epithelial lining fluid albumin associated with smoking and interstitial lung disease.

The European respiratory journal·1993
Same author

Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma.

Chest·1992
Same author

Smoking-induced changes in epithelial lining fluid volume, cell density and protein.

The European respiratory journal·1992

Area of Science:

  • Pulmonology
  • Pharmacology
  • Clinical Medicine

Background:

  • Adverse drug reactions can manifest as pulmonary diseases.
  • Understanding drug-induced lung conditions is crucial for patient care.

Purpose of the Study:

  • To review types of drug-induced pulmonary disease reported in Australia.
  • To compare Australian data with international reports on drug-induced lung conditions.

Main Methods:

  • Analysis of pulmonary side effect reports to the Australian Adverse Drug Reaction Advisory Committee (1972-1991).
  • Inclusion of reports involving large patient numbers to minimize bias.
  • Comparison of incidence data from other countries with Australian reports.

Main Results:

  • Pulmonary side effects constituted 7.7% of reported adverse drug reactions in Australia over 19 years.
  • Airway dysfunction syndromes accounted for 55% of these pulmonary reactions.
  • Beta-blocking drugs and radio contrast media were frequently implicated in causing bronchospasm and cough.

Conclusions:

  • Medical practitioners should maintain a high index of suspicion for drug-induced pulmonary disease.
  • Prompt drug withdrawal and appropriate management can lead to reversible outcomes.
  • Common drug-induced lung diseases affecting airways and lung parenchyma are reviewed.

Related Experiment Videos